CRISPR/Cas3 Platform Developer Locus Biosciences Raises $19M in Series A Financing – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology NewsCRISPR/Cas3 Platform Developer Locus Biosciences Raises $19M in Series A FinancingGenetic Engineering & Biotechnology NewsLocus Biosciences, developer of a next-generation CRISPR-Cas platform for precision antimi… Continue reading
